
|Articles|June 27, 2023
Opioid Reformulation for Abuse Deterrence - Filed as a CMC Supplement in Less Than a Year
Author(s)Societal CDMO
It is no secret that Opioid abuse is an ongoing public health emergency. Societal™’s client stood at an impasse in pursuit of providing pain relief to patients, while following the recommendation of the FDA to reformulate the product for abuse deterrence.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
The Year of AI: 2025’s Bio/pharma Upskilling Revolution
2
Strategies for Building Pharmaceutical Supply Chain Resilience in a Shifting Market
3
Onshoring Requires a Plan for Training
4
How GLP-1s, Digital Tech, and 505(b)(2) Strategies Are Reshaping the CDMO Landscape
5